Skip to main content

Lipe & Dalton

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1570396 SYRACUSE, NY

Position in REGN

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$223,292
-$15,215 QoQ
Shares Held
289
-6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

All Filings in REGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $223,292 289
2025-12-31 $238,507 309
2024-12-31 $191,616 269
2024-09-30 $282,783 269
2024-06-30 $282,727 269
2024-03-31 $258,909 269
2023-12-31 $236,260 269
2023-09-30 $221,376 269
2023-06-30 $193,287 269
2023-03-31 $237,462 289
2022-12-31 $208,510 289
2022-09-30 $212,860 309
2022-06-30 $182,659 309
2022-03-31 $215,811 309
2021-12-31 $195,139 309
2021-09-30 $126,482 209
2021-06-30 $116,734 209